The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis. Kowalec K, Carleton B, Tremlett H Mult Scler Relat Disord. 2013 Jul; 2(3):183-92. Epub 2013 Jan 10. PMID: 25877724. Abstract CommentRecommendBookmarkWatch